共 50 条
- [41] The challenges of pharmacoepidemiology of orphan drugs in rare diseases THERAPIE, 2020, 75 (02): : 215 - 220
- [42] Characteristics of drugs for ultra-rare diseases versus drugs for other rare diseases in HTA submissions made to the CADTH CDR Orphanet Journal of Rare Diseases, 13
- [43] Characteristics of drugs for ultra-rare diseases versus drugs for other rare diseases in HTA submissions made to the CADTH CDR ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
- [45] FINANCING OF MEDICINES FOR TREATMENT OF RARE DISEASES OF THE NERVOUS SYSTEM. ORPHAN DRUGS IN RARE NEUROLOGICAL DISEASES IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2016, 69 (1-2): : 37 - 45
- [46] CARE OF RARE DISEASES Transfer of high cost drugs to NICE risks fragmentation of care of rare diseases BRITISH MEDICAL JOURNAL, 2012, 345
- [49] FDA Funds Development of Drugs and Devices for Rare Diseases JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (20): : 2140 - 2140